Bitcoin and ether head for second week of losses: CNBC Crypto World

Bitcoin and ether head for second week of losses: CNBC Crypto World


Share

CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry. On today’s show, Hong Fang of OKX breaks down crypto’s recent slide and whether institutional investors are sticking to the sidelines.



Source

OpenAI identifies security issue involving third-party tool, says user data was not accessed
World

OpenAI identifies security issue involving third-party tool, says user data was not accessed

Samuel Boivin | Nurphoto | Getty Images OpenAI said on Friday it had identified a security issue involving a third-party developer tool called Axios and is taking steps to protect the process that certifies its macOS applications are legitimate OpenAI apps. The ChatGPT maker said it found no evidence that its user data was accessed, […]

Read More
U.S.-Iran talks set to begin in Pakistani capital after delegations arrive
World

U.S.-Iran talks set to begin in Pakistani capital after delegations arrive

TOPSHOT – A policeman stands guard in front of a digital screen displaying news of USIran peace talks along a road in Islamabad on April 10, 2026. (Photo by Farooq NAEEM / AFP via Getty Images) Farooq Naeem | Afp | Getty Images Pakistan confirmed the arrival of a delegation of Iranian negotiators ahead of […]

Read More
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
World

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing […]

Read More